Immunitybio, Inc.
Clinical trials sponsored by Immunitybio, Inc., explained in plain language.
-
New drug aims to fight tough pancreatic cancer
Disease control CompletedThis early-phase trial tested a new drug called HCW9218 in 21 people with advanced pancreatic cancer that had stopped responding to standard treatments. The drug is designed to help the immune system attack the cancer while blocking a protein that helps tumors grow. The main goal…
Phase: PHASE1, PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Healthy donor cells tested with immune booster N-803
Knowledge-focused CompletedThis early-stage study looked at how a drug called N-803 affects natural killer cells collected from 10 healthy volunteers. The main goal was to check for side effects and see if the drug helps these immune cells grow. It was a small, safety-focused trial with no direct treatment…
Phase: PHASE1 • Sponsor: ImmunityBio, Inc. • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:04 UTC